Huaxiang Wang, Junjun Li, Xiuling Zhu, Ruling Wang, Yunyan Wan. "A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib." Scientific Reports, 2025. doi:10.1038/s41598-025-85831-4